Verrica Pharmaceuticals Announces FDA Approval of YCANTH™ (cantharidin) topical solution 0.7%. News Release. Verrica. July 21, 2023.
First Drug for Skin Infection from Pox Virus Approved by FDA
Share This Story, Choose Your Platform!
About the Author:
